Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PF4-heparin antibodies during ECMO: incidence, course, and outcomes.

Literature DB >> 26903478

PF4-heparin antibodies during ECMO: incidence, course, and outcomes.

Florent Laverdure¹, Virginie Louvain-Quintard², Talna Kortchinsky¹, Saïda Rezaiguïa-Delclaux¹, Audrey Imbert¹, François Stéphan³.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2016 PMID： 26903478 DOI： 10.1007/s00134-016-4262-2

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

5 in total

1. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.

Authors: Steven Baroletti; Shelley Hurwitz; Nicole A S Conti; John Fanikos; Gregory Piazza; Samuel Z Goldhaber
Journal: Am J Med Date: 2011-11-08 Impact factor: 4.965

2. Clinical and biologic features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU.

Authors: Virginie Trehel-Tursis; Virginie Louvain-Quintard; Youssef Zarrouki; Audrey Imbert; Sylvie Doubine; François Stéphan
Journal: Chest Date: 2012-10 Impact factor: 9.410

3. What's new about heparin-induced thrombocytopenia type II.

Authors: Yasser Sakr
Journal: Intensive Care Med Date: 2015-04-23 Impact factor: 17.440

4. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.

Authors: T L Bauer; G Arepally; B A Konkle; B Mestichelli; S S Shapiro; D B Cines; M Poncz; S McNulty; J Amiral; W W Hauck; R N Edie; J D Mannion
Journal: Circulation Date: 1997-03-04 Impact factor: 29.690

5. Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.

Authors: Daryl Glick; Amy L Dzierba; Darryl Abrams; Justin Muir; Andrew Eisenberger; David Diuguid; Erik Abel; Cara Agerstrand; Matthew Bacchetta; Daniel Brodie
Journal: J Crit Care Date: 2015-08-01 Impact factor: 3.425

5 in total

8 in total

1. Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.

Authors: Andreas Koster; Edis Ljajikj; David Faraoni
Journal: Ann Cardiothorac Surg Date: 2019-01

2. Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review.

Authors: Han Zhong; Ming-Li Zhu; Yue-Tian Yu; Wen Li; Shun-Peng Xing; Xian-Yuan Zhao; Wei-Jun Wang; Zhi-Chun Gu; Yuan Gao
Journal: Front Pharmacol Date: 2020-09-11 Impact factor: 5.810

8. Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports.

Authors: Frank Bidar; Guillaume Hékimian; Isabelle Martin-Toutain; Guillaume Lebreton; Alain Combes; Corinne Frère
Journal: J Artif Organs Date: 2020-08-12 Impact factor: 1.731

8 in total

PF4-heparin antibodies during ECMO: incidence, course, and outcomes.

1. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.

2. Clinical and biologic features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU.

3. What's new about heparin-induced thrombocytopenia type II.

4. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.

5. Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.

1. Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.

2. Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review.

3. Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study.

Review 4. Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes.

Review 5. Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis.

6. Heparin-Induced Thrombocytopenia in COVID-19: A Systematic Review.

Review 7. Extracorporeal life support in cardiogenic shock: indications and management in current practice.

8. Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports.